HIGHLIGHTS OF UK ACTIVITY AT

BIO 2018 4-7 JUNE 2018, BOSTON, MA, USA

BREAKFAST

MONDAY, JUNE 4, 2018, 8-11AM

Wolf, Greenfield & Sacks, 600 Atlantic Avenue, Boston (short walk from Convention Centre)

Start your week at BIO with a hearty breakfast hosted by the UK at the:

UK BIO INTERNATIONAL NETWORKING BREAKFAST

“The NHS at 70, opportunities and challenges, from tackling AMR to real-world trial delivery”

Organised by the Northern Health Science Alliance and sponsored by the UK Department for International Trade and Alderley Park, join us at our host venue of Wolf, Greenfield & Sacks.

Dr Hakim Yadi OBE, CEO of the NHSA, will talk through the opportunities in data, digital heath and real-world trial infrastructure in the UK, he will be joined by Dr Peter Jackson, Chief Executive of the AMR Centre in Alderley Park, UK, Fiona Marston, Director, Centre of Excellence in Infectious Diseases Research, UK and James Brayer, Director of Market Development US, Oxford Nanopore Technologies.

 Places are free but limited, please register as soon as possible to secure your place on Eventbrite at https://tinyurl.com/yb3agvsw

UK RECEPTION

TUESDAY, JUNE 5 2018, 5PM-6.30PM

On-stand reception at the UK Pavilion. Join the UK delegation for this informal gathering, kindly supported by the UK Department of International Trade and partners.

DON’T MISS: SEMINAR/PANEL

WEDNESDAY JUNE 6, 2016, 11AM-12PM

JOIN US IN ROOM 251, LEVEL 2 FOR:

THE VALUE OF ADDRESSING AMR

In spite of the importance of effective antimicrobials to modern medicine and growing recognition of the health and economic threat posed by antimicrobial resistance (AMR), market challenges have impeded sustainable investment in the development of new products to prevent and treat bacterial infections.
There are ongoing conversations on incentives to stimulate AMR-relevant research and development. New value frameworks that capture the full benefit of these products are fundamental to enable successful implementation of these incentives. These frameworks can be used to ensure the incentives for development are commensurate with the benefits that novel antibiotics and vaccines bring patients, health care systems, and society.

This session will examine how we can better assess the value of new antimicrobials to individuals, health care systems, and society; how the unique attributes of novel antibiotics can be considered in reimbursement decision-making.

Speakers will include:

Professor Ian Greer, Vice-President and Dean, Faculty of Biology Medicine and Health, University of Manchester, UK.

Professor Colm Leonard, Clinical Adviser, National Institute for Health and Care Excellence (NICE), Manchester, UK.

Professor Mark Sculpher, Professor of Health Economics, University of York, UK.

Dr Evan Loh, Chief Operating Officer and Medical Director, Paratek, USA.

MEET THE EXPERTS

MEET THE PANELLISTS AND FIND OUT MORE ABOUT UK FUNDING FROM INNOVATE UK AT THE UK PAVILION ON WEDNESDAY JUNE 6, FROM 1PM – 3PM

This is your opportunity to continue the discussion with our speakers as they will be joining the UK Pavilion from 1-3pm on Wednesday June 6, after the main panel session.  They will also be joined by UK Funding specialists, Elaine Evans and Cynthia Bullock from Innovate UK.

Further information:

Catherine Gresty

Event Management Associate
Northern Health Science Alliance Ltd

Mob: +44 (0) 7985 982786

catherine@thenhsa.co.uk

Suzanne Ali-Hassan

Head of Corporate Engagement
Northern Health Science Alliance Ltd
Tel: +44 (0) 2034 099 395; Mob: +44 (0) 7342 882 389

suzanne@thenhsa.co.uk

Hannah Davies

Head of External Affairs
Northern Health Science Alliance Ltd

Tel: 07342882383
E-mail: Hannah.Davies@theNHSA.co.uk
Twitter: @The_NHSA